Current Management of Upper Gastrointestinal (GI) Bleeding: The Role of Surgery, Endoscopy and Interventional Radiology
Upper gastrointestinal (GI) bleeding is commonly managed in a multidisciplinary fashion, including interventional radiology, endoscopy, and surgery. This panel will explore the role each of these entities plays in the management of upper GI bleeding. This session will also discuss which patients should undergo operative management, as well as the timing of operation and procedural choices.
Moderator: Mayur Narayan, MD, MPH, MBA, MHPE, FACS, New York, NY
Co-Moderator: Jimmie N. Collins, MD, FACS, Norfolk, VA
UGI (Upper Gastrointestinal) Bleeds: Never Fear, GI Is Here
Hari Conjeevaram, MD, Ann Arbor, MI
UGI Bleeds: When Push Comes to Shove, the Solution Starts with the Wire
Resmi Charalel, MD, New York, NY
UGI Bleeds: Surgeon as Definitive Manager or Benchwarmer?
Amy P. Rushing, MD, FACS, Columbus, OH
Sponsored by the Advisory Council for General Surgery and the Bariatric Advisory Committee
- Practicing surgeons
- Apply new knowledge and ideas to improve their surgical practice
- Adapt concepts and quality measures in support of research advancements
- Enhance the quality of patient care
For questions about the course, please contact firstname.lastname@example.org.
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any commercial interest. For additional information, please visit the ACCME website.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during a activity, please report it on the evaluation.
(Download the full list of disclosures).
Faculty and Disclosures
Amy Page Rushing MD, FACS - Nothing to Disclose
Hari Conjeevaram MD, MSc - Nothing to Disclose
Jay N. Collins MD, FACS - Nothing to Disclose
Mayur Narayan, MD, MPH, MBA, MHPE, FACS - Gel E Life Sciences: Stock Options: Investor/Clinical Advisory Board
Resmi Charalel MD - Nothing to Disclose
Program Committee and Disclosures
CHAIR: Henri R. Ford, MD, MHA, FACS, FAAP, FRCSEng(Hon), Miami, FL - Nothing to Disclosure
VICE-CHAIR: David T. Cooke, MD, FACS, Sacramento, CA - Nothing to Disclosure
David C. Borgstrom, MD, FACS, Morgantown, WV - Nothing to Disclosure
Daniel L. Dent, MD, FACS, San Antonio, TX - Nothing to Disclosure
Roger R. Dmochowski, MD, FACS, Nashville, TN - Allergen: Honoraria: Consultant
Cynthia D. Downard, MD, FACS, Louisville, KY - Nothing to Disclosure
Audra A. Duncan, MD, FACS, London, ON - Nothing to Disclosure
Mariam F. Eskander, MD, Boston, MA - Nothing to Disclosure
Paula Ferrada, MD, FACS, Richmond, VA - Nothing to Disclosure
Neil H. Hyman, MD, FACS, Chicago, IL - Nothing to Disclosure
Martin S. Karpeh, Jr., MD, FACS, New York, NY - Nothing to Disclosure
Dennis H. Kraus, MD, FACS, New York, NY - Nothing to Disclosure
Kenneth W. Sharp, MD, FACS, Nashville, TN - Nothing to Disclosure
Daniel M. Herron, MD, FACS, FASBMS, New York, NY - Nothing to Disclosure
Edith Tzeng, MD, FACS, Pittsburgh, PA - Nothing to Disclosure
Barbara Lee Bass, MD, FACS, FRCSEng(Hon), FRCSI(Hon), FCOSECSA(Hon), Houston, TX - Nothing to Disclosure
Quan-Yang Duh, MD, FACS, San Francisco, CA - Nothing to Disclosure
B. J. Hancock, MD, FACS, FRCSC, Winnipeg, MB - Nothing to Disclosure
Ronald V. Maier, MD, FACS, FRCSEd(Hon), Seattle, WA - Nothing to Disclosure
Note: Residents will receive a Certificate of Completion.
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Certificate of Completion
- 1.50 Self Assessment Credit